[{"id":"cb7cf5c0-8944-4d69-b635-1435a9e5f4ec","acronym":"BVAC-B","url":"https://clinicaltrials.gov/study/NCT03425773","created_at":"2021-01-18T16:54:03.809Z","updated_at":"2024-07-02T16:36:49.766Z","phase":"Phase 1","brief_title":"Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care","source_id_and_acronym":"NCT03425773 - BVAC-B","lead_sponsor":"Cellid Co., Ltd.","biomarkers":" HER-2 • CD4","pipe":"","alterations":" ","tags":["HER-2 • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BVAC-B"],"overall_status":"Completed","enrollment":" Enrollment 8","initiation":"Initiation: 02/26/2018","start_date":" 02/26/2018","primary_txt":" Primary completion: 05/13/2019","primary_completion_date":" 05/13/2019","study_txt":" Completion: 05/13/2019","study_completion_date":" 05/13/2019","last_update_posted":"2020-02-20"}]